Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
47°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
733.51
+8.64 (+1.19%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
75
76
Next >
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
October 06, 2023
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior.
Via
Benzinga
Stock Market Ends On High Note Even As Yields Soar; Tesla In Focus: Weekly Review
October 06, 2023
A rally attempt continues amid soaring Treasury yields.
Via
Investor's Business Daily
Eli Lilly's Upcoming Obesity Drugs Highlight Bright Future, Says Optimistic Analyst
October 06, 2023
Shares of Eli Lilly And Co (NYSE: LLY) were climbing during Friday's trading session. The stock has been under pressure for the past three months, due to macro uncertainties and not fundamental...
Via
Benzinga
Looking At Eli Lilly's Recent Unusual Options Activity
October 06, 2023
Via
Benzinga
Here's How Much $100 Invested In Eli Lilly 5 Years Ago Would Be Worth Today
October 04, 2023
Via
Benzinga
Check Out What Whales Are Doing With LLY
October 04, 2023
Via
Benzinga
Analyst Ratings for Eli Lilly
October 02, 2023
Via
Benzinga
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
October 06, 2023
Eli Lilly's drug looks better on paper, but Ozempic was on the market first.
Via
The Motley Fool
Should You Sell This Stock After Another Regulatory Headwind?
October 06, 2023
This company has grabbed plenty of headlines this year, and they haven't all been good.
Via
The Motley Fool
Why Point BioPharma Global Stock Skyrocketed 86% This Week
October 05, 2023
Point Biopharma is being acquired by Eli Lilly. Here's what investors need to know.
Via
The Motley Fool
Thinking Of Buying Alexandria Real Estate Equities? Here Are The Properties And Tenants You'd Add To Your Portfolio
October 05, 2023
Via
Benzinga
Biggest Oil Drop In A Year On Biden Security Plan, Magnificent 7 Stocks Do Not Like The New Data
October 05, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
October 05, 2023
This stock puts the "big" in big pharma after massive gains in recent years.
Via
The Motley Fool
Why Eli Lilly Stock Was Looking Sickly Today
October 03, 2023
Investors weren't necessarily satisfied with their company's latest asset buy.
Via
The Motley Fool
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
October 03, 2023
U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Eli Lilly Stock Is Trading Lower Today
October 03, 2023
Eli Lilly and Company (NYSE: LLY) shares are trading lower Tuesday after the company announced the acquisition of POINT Biopharma for an aggregate purchase price
Via
Benzinga
Why Shares of Point Biopharma Global Are Soaring Tuesday
October 03, 2023
The company entered into a buyout agreement with Eli Lilly.
Via
The Motley Fool
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration
Via
Benzinga
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 03, 2023
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company.
Via
Benzinga
Nasdaq Down Over 200 Points; US Job Openings Rise In August
October 03, 2023
U.S. stocks extended losses midway through trading, with the Nasdaq Composite falling more than 200 points on Tuesday. The Dow traded down 1.06% to 33,078.27 while the NASDAQ fell 1.60% to 13,094.83....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Point Biopharma Stock Nearly Doubles On Eli Lilly Deal
October 03, 2023
Eli Lilly is spending $1.4 billion on buying Point Biopharma Global Inc. Point Biopharma is a radiopharmaceutical company focused on cancer treatment.
Via
Talk Markets
S&P 500 Forecast: Stocks Drop As Treasury Yields Surge
October 03, 2023
US stocks are heading lower as US treasury yields surge to a 16 year high.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
October 03, 2023
Benzinga
Via
Benzinga
Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
October 03, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Vericity, Inc. (NASDAQ: VERY) shares climbed...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Falls Over 100 Points; McCormick Sales Miss Views
October 03, 2023
U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.37% to 33,310.99 while the NASDAQ fell...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Point Biopharma Stock Launches 84% On Eli Lilly's $1.4 Billion Takeover
October 03, 2023
The company is working on targeted radiation therapy with prostate cancer results up next.
Via
Investor's Business Daily
Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today?
October 03, 2023
Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global Inc (NASDAQ: PNT) at $12.50 per share in cash, an aggregate of
Via
Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive...
Via
Benzinga
Why Is Point Biopharma (PNT) Stock Up 84% Today?
October 03, 2023
Point Biopharma stock is heading higher on Tuesday as investors react to news of Eli Lilly acquiring the shares of PNT for $12.50 each.
Via
InvestorPlace
Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
October 03, 2023
Soleno Therapeutics is working on a treatment for Prader Willi syndrome, a genetic disease that causes obesity.
Via
Investor's Business Daily
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
75
76
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.